At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 24 enrolled
Drug / intervention
Ascorbic Acid +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Ascorbic Acid (Vitamin C) Infusion in Human Sepsis
In Brief
A Phase 2 clinical trial evaluating Ascorbic Acid and Placebo for Sepsis and 3 related conditions. Completed, enrolled 24 participants across 1 site.
Detailed Summary
The major goal of this project is to determine whether intravenously infused ascorbic acid is safe for use as a viable therapeutic strategy in adult humans with sepsis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSepsis, Septic Shock, Hypotension, Acute Lung Injury
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2010
First PostedSep 2011
Primary CompletionSep 2012
TodayJul 2026
First PostedSep 14, 2011
Enrollment StartMay 1, 2010
Primary CompletionSep 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 14.8 years ago
Interventions
Ascorbic Aciddrug
The infusion of either a high dose of ascorbic acid, low dose ascorbic acid, or placebo
Placebodrug